Skip to main content

Journal of Cancer Survivorship

Ausgabe 5/2023

Inhalt (26 Artikel)

Racial disparities in follow-up care of early-stage lung cancer survivors

Jyoti Malhotra, Lisa E. Paddock, Yong Lin, Sharon R. Pine, Muhammad H. Habib, Antoinette Stroup, Sharon Manne

Importance of primary care for underserved cancer patients with multiple chronic conditions

Katelyn K. Jetelina, Simon Craddock Lee, Quiera S. Booker-Nubie, Udoka C. Obinwa, Hong Zhu, Michael E. Miller, Navid Sadeghi, Umber Dickerson, Bijal A. Balasubramanian

Original Research

Optimizing cancer survivorship in primary care: patient experiences from the Johns Hopkins Primary Care for Cancer Survivors clinic

Youngjee Choi, Elaina Parrillo, Jennifer Wenzel, Victoria F. Grabinski, Aamna Kabani, Kimberly S. Peairs

Open Access Review

Availability and use of web-based interventions for patients with head and neck cancer: a scoping review

Rosemary Kelly, Peter Gordon, Ruth Thompson, Cherith Semple

Patient preferences and comfort for cancer survivorship models of care: results of an online survey

Deanna J. Attai, Matthew S. Katz, Elani Streja, Jui-Ting Hsiung, Maria V. Marroquin, Beverly A. Zavaleta, Larissa Nekhlyudov

Facilitators and barriers to employment for rural women cancer survivors

Emily Hallgren, Britni L. Ayers, Ramey Moore, Rachel S. Purvis, Pearl A. McElfish, Sanjay Maraboyina, Gwendolyn Bryant-Smith

The effect of pediatric central nervous system tumors on identity in young adult survivors: a project REACH study

Chantel Cacciotti, Lydia Larocque Chevalier, Cheryl Medeiros-Nancarrow, Christopher Recklitis, Tabitha M. Cooney

Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey

Clément Magnani, Allan Ben Smith, Dominique Rey, Aline Sarradon-Eck, Marie Préau, Marc-Karim Bendiane, Anne-Déborah Bouhnik, Julien Mancini

Open Access

Effects of a 12-week supervised resistance training program, combined with home-based physical activity, on physical fitness and quality of life in female breast cancer survivors: the EFICAN randomized controlled trial

Alberto Soriano-Maldonado, David M. Díez-Fernández, Alba Esteban-Simón, Manuel A. Rodríguez-Pérez, Eva Artés-Rodríguez, Miguel A. Casimiro-Artés, Herminia Moreno-Martos, Antonio Toro-de-Federico, Nur Hachem-Salas, Cecilie Bartholdy, Marius Henriksen, Antonio J. Casimiro-Andújar

Effect of exercise on body composition among women with ovarian cancer

Anlan Cao, Brenda Cartmel, Fang-Yong Li, Linda T. Gottlieb, Maura Harrigan, Jennifer A. Ligibel, Radhika Gogoi, Peter E. Schwartz, Melinda L. Irwin, Leah M. Ferrucci

Beyond depression: correlates of well-being in young adult survivors of childhood cancers

Yoonji Kim, Anamara Ritt-Olson, Jessica Tobin, Marcie Haydon, Joel Milam

Open Access

The association of circadian parameters and the clustering of fatigue, depression, and sleep problems in breast cancer survivors: a latent class analysis

Belle H. de Rooij, Imogen Ramsey, Felix J. Clouth, Nadia Corsini, Jane S. Heyworth, Brigid M. Lynch, Jeff K. Vallance, Terry Boyle

Original Research

Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow-up study

Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho

Self-reported symptoms among cancer survivors in the Women’s Health Initiative (WHI) Life and Longevity after Cancer (LILAC) cohort

Brittany M. Bernardo, Michael L. Pennell, Michelle J. Naughton, Nils Patrik Brodin, Marian L. Neuhouser, Rowan T. Chlebowski, Electra D. Paskett

Disparities in fertility preservation use among adolescent and young adult women with cancer

Clare Meernik, Stephanie M. Engel, Ally Wardell, Christopher D. Baggett, Parul Gupta, Nidia Rodriguez-Ormaza, Barbara Luke, Valerie L. Baker, Ethan Wantman, Jose Alejandro Rauh-Hain, Jennifer E. Mersereau, Andrew F. Olshan, Andrew B. Smitherman, Jianwen Cai, Hazel B. Nichols

The Health of Women (HOW) Study®: a web-based survey of breast cancer risk factors, diagnosis, and treatment

Jennifer Lyn Guida, Paige Green, Jessica Clague-DeHart, Leah Eshraghi, Nicole Laurita, Mary O’Connell, Susan Love

Financial navigation: Staff perspectives on patients’ financial burden of cancer care

Katherine A. Yeager, Whitney E. Zahnd, Jan M. Eberth, Robin C. Vanderpool, Catherine Rohweder, Randall Teal, Maihan Vu, Lindsay Stradtman, Elizabeth L. Frost, Erika Trapl, Sarah Koopman Gonzalez, Thuy Vu, Linda K. Ko, Allison Cole, Paige E. Farris, Jackilen Shannon, Natoshia Askelson, Laura Seegmiller, Arica White, Jean Edward, Melinda Davis, Victoria Petermann, Stephanie B Wheeler

Open Access

Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance

Jet W. Ankersmid, Constance H. C. Drossaert, Yvonne E. A. van Riet, Luc J. A. Strobbe, Sabine Siesling

Original Research

Self-management goals of cancer survivors with an ostomy

Elizabeth Ercolano, Marcia Grant, Virginia Sun, Nancy Tallman, Julia Mo, Pamela Pitcher, Mark C. Hornbrook, Peter Yonsetto, Octavio Bojorquez, Sabreen Raza, Ruth McCorkle, Robert S. Krouse

Functional aging trajectories of older cancer survivors: a latent growth analysis of the US Health and Retirement Study

Ashly C. Westrick, Kenneth M. Langa, Marisa Eastman, Monica Ospina-Romero, Megan A. Mullins, Lindsay C. Kobayashi

Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis

Matteo Malgaroli, Kristin L. Szuhany, Gabriella Riley, Carly D. Miron, Jae Hyung Park, Jane Rosenthal, Abraham Chachoua, Marleen Meyers, Naomi M. Simon

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.